Market Overview:
The global aerosol therapy market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of respiratory diseases, growing geriatric population, and technological advancements in aerosol therapy devices. Based on type, the global aerosol therapy market is segmented into inhalers, nebulizers, and bronchodilators. Inhalers are further sub-segmented into metered dose inhalers (MDIs) and dry powder inhalers (DPIs). Nebulizers are further sub-segmented into ultrasonic nebulizers and mesh nebulizers. Bronchodilators are further sub-segmented into short-acting beta agonists (SABAs), long-acting beta agonists (LABAs), anticholinergics, methylxanthines, and corticosteroids/inhaled glucocorticoids. Based on application, the global aerosol therapy market is segmented into hospitals & clinics; ambulatory surgical centers; individual users; and other applications such as veterinary use & research institutes. Hospitals & clinics held the largest share of the global aerosol therapy market in 2017 owing to rising demand for advanced therapies for treating respiratory diseases among patients admitted in these settings.
Product Definition:
Aerosol therapy is a form of medication delivery in which a drug is delivered to the lungs as an aerosol. This method bypasses the gastrointestinal tract and allows for direct delivery to the lungs, where it can more effectively interact with the respiratory system.
Inhalers:
Inhalers are devices used to inhale medication into the lungs. They are most commonly used for treating respiratory disorders such as asthma, Chronic Obstructive Pulmonary Disease (COPD), bronchitis, and pulmonary fibrosis. Inhalers can also be used for treating patients with overdosing on opioids or other drugs that are found in their systems when they overdose.
Nebulizers:
Nebulizers are devices that propel a stream of liquid or gas into the air. They are used to treat respiratory disorders such as asthma, Chronic Obstructive Pulmonary Disease (COPD), and sleep apnea. Nebulizers can also be used for treating diseases such as Parkinson's disease, Alzheimer's disease, cancer and others.
Application Insights:
The clinics, ambulatory surgical centers and hospitals segment dominated the market in 2017. This is owing to factors such as an increase in the prevalence of asthma and other lung diseases, growing awareness about the benefits of aerosol therapy among patients and healthcare providers, increasing government support for improving access to care for patients with chronic conditions, high usage rates of bronchodilators among patients seeking treatment at outpatient facilities or emergency rooms at hospitals.
In addition, a rise in demand for rapid diagnosis along with effective treatment is expected to drive growth over the forecast period. Increasing cases of infectious diseases coupled with rising geriatric population across various regions are anticipated to drive demand for aerosol therapy during hospital stays. In addition, favorable reimbursement policies are likely to boost industry growth over the forecast period.
Regional Analysis:
North America dominated the global market in 2017 owing to favorable reimbursement policies, high awareness levels about the product benefits, and presence of key manufacturers. The region is expected to maintain its dominance over the forecast period due to increasing prevalence of COPD coupled with growing healthcare expenditure.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising disposable income and improving healthcare infrastructure in emerging countries such as China & India. Furthermore, government initiatives for increasing public health insurance coverage are likely boost revenue generation in this region. For instance, National Health Mission 2015-16 introduced universal access component for primary care services which includes diagnosis & treatment of respiratory diseases including asthma and chronic cough among others at outpatient clinics along with hospitals/polyclinics under Integrated Care Systems (ICS).
Growth Factors:
- Increasing prevalence of respiratory diseases: The global Aerosol Therapy market is expected to grow at a CAGR of 7.5% during the forecast period, owing to the increasing prevalence of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis.
- Technological advancements: The advent of novel technologies in aerosol therapy devices is expected to drive the growth of this market during the forecast period. For instance, in January 2017, Philips Healthcare announced the launch of its new “Aera” handheld aerosol therapy device that delivers high-resolution imaging and personalized treatment plans for patients with respiratory conditions such as asthma and COPD.
- Rising demand for home-based care: There is a rising demand for home-based care among geriatric population due to increasing awareness about Aerosol Therapy devices and their benefits over traditional treatments methods such as oral medications or injections. This is likely to fuel the growth of this market during the forecast period.
- Becton Dickinson announced its plans invest USD 100 million over five years towards R&D initiatives aimed at developing next generation medical technologies including those related to aerosol therapies.. This is likelyto boostthegrowth
Scope Of The Report
Report Attributes
Report Details
Report Title
Aerosol Therapy Market Research Report
By Type
Inhalers, Nebulizers, Bronchodilators
By Application
Hospitals, Clinics, Ambulatory Surgical Centers, Individual
By Companies
Merck, Boehringer Ingelheim, GlaxoSmithKline, AstraZeneca, Novartis, Teva Pharmaceuticals, Opko Health, Omron Healthcare, Medtronic, GE Healthcare, Philips Healthcare, Agilent Technologies, GF Health Products
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
175
Number of Tables & Figures
123
Customization Available
Yes, the report can be customized as per your need.
Global Aerosol Therapy Market Report Segments:
The global Aerosol Therapy market is segmented on the basis of:
Types
Inhalers, Nebulizers, Bronchodilators
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Ambulatory Surgical Centers, Individual
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Merck
- Boehringer Ingelheim
- GlaxoSmithKline
- AstraZeneca
- Novartis
- Teva Pharmaceuticals
- Opko Health
- Omron Healthcare
- Medtronic
- GE Healthcare
- Philips Healthcare
- Agilent Technologies
- GF Health Products
Highlights of The Aerosol Therapy Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Inhalers
- Nebulizers
- Bronchodilators
- By Application:
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Individual
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Aerosol Therapy Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Aerosol therapy is the use of a pressurized gas or mist to deliver medication or other treatment to a patient. Aerosols are often used in hospitals and clinics to treat infections, respiratory problems, and other medical conditions.
Some of the key players operating in the aerosol therapy market are Merck, Boehringer Ingelheim, GlaxoSmithKline, AstraZeneca, Novartis, Teva Pharmaceuticals, Opko Health, Omron Healthcare, Medtronic, GE Healthcare, Philips Healthcare, Agilent Technologies, GF Health Products.
The aerosol therapy market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Aerosol Therapy Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Aerosol Therapy Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Aerosol Therapy Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Aerosol Therapy Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Aerosol Therapy Market Size & Forecast, 2018-2028
4.5.1 Aerosol Therapy Market Size and Y-o-Y Growth
4.5.2 Aerosol Therapy Market Absolute $ Opportunity
Chapter 5 Global Aerosol Therapy Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Aerosol Therapy Market Size Forecast by Type
5.2.1 Inhalers
5.2.2 Nebulizers
5.2.3 Bronchodilators
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Aerosol Therapy Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Aerosol Therapy Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Ambulatory Surgical Centers
6.2.4 Individual
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Aerosol Therapy Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Aerosol Therapy Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Aerosol Therapy Analysis and Forecast
9.1 Introduction
9.2 North America Aerosol Therapy Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Aerosol Therapy Market Size Forecast by Type
9.6.1 Inhalers
9.6.2 Nebulizers
9.6.3 Bronchodilators
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Aerosol Therapy Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Ambulatory Surgical Centers
9.10.4 Individual
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Aerosol Therapy Analysis and Forecast
10.1 Introduction
10.2 Europe Aerosol Therapy Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Aerosol Therapy Market Size Forecast by Type
10.6.1 Inhalers
10.6.2 Nebulizers
10.6.3 Bronchodilators
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Aerosol Therapy Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Ambulatory Surgical Centers
10.10.4 Individual
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Aerosol Therapy Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Aerosol Therapy Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Aerosol Therapy Market Size Forecast by Type
11.6.1 Inhalers
11.6.2 Nebulizers
11.6.3 Bronchodilators
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Aerosol Therapy Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Ambulatory Surgical Centers
11.10.4 Individual
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Aerosol Therapy Analysis and Forecast
12.1 Introduction
12.2 Latin America Aerosol Therapy Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Aerosol Therapy Market Size Forecast by Type
12.6.1 Inhalers
12.6.2 Nebulizers
12.6.3 Bronchodilators
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Aerosol Therapy Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Ambulatory Surgical Centers
12.10.4 Individual
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Aerosol Therapy Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Aerosol Therapy Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Aerosol Therapy Market Size Forecast by Type
13.6.1 Inhalers
13.6.2 Nebulizers
13.6.3 Bronchodilators
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Aerosol Therapy Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Ambulatory Surgical Centers
13.10.4 Individual
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Aerosol Therapy Market: Competitive Dashboard
14.2 Global Aerosol Therapy Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Merck
14.3.2 Boehringer Ingelheim
14.3.3 GlaxoSmithKline
14.3.4 AstraZeneca
14.3.5 Novartis
14.3.6 Teva Pharmaceuticals
14.3.7 Opko Health
14.3.8 Omron Healthcare
14.3.9 Medtronic
14.3.10 GE Healthcare
14.3.11 Philips Healthcare
14.3.12 Agilent Technologies
14.3.13 GF Health Products
